Clinical Trial Update: Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients [EARLY_Phase 1]

View source ↗

Summary

A clinical trial evaluating oral vancomycin, probiotics, and placebo to prevent Clostridioides difficile infection in colonized patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Probiotic (probiotic)
• Vancomycin (vancomycin)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Clostridium Difficile Colonization, Clostridium Difficile Diarrhea | EARLY_Phase 1 | Status: WITHDRAWN